Buy Eribulin Mesylate 0.5mg/ml Injection from Trusted Global Exporter in India
Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter and global supplier of Eribulin Mesylate 0.5mg/ml Injection from India, delivering high-quality oncology medicines with fast, reliable, and affordable shipping solutions worldwide. We specialize in pharmaceutical exports to South Africa, including Gauteng, Western Cape, KwaZulu-Natal, Eastern Cape, and Free State.
For Orders & Enquiries
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
What is Eribulin Mesylate 0.5mg/ml Injection?
Eribulin Mesylate Injection is an oncology medication classified as a microtubule inhibitor and is commonly used in advanced cancer treatment protocols under medical supervision. It is available in a concentration of 0.5mg/ml and supplied for institutional and regulated pharmaceutical markets. The formulation strength commonly marketed internationally includes 1mg/2ml single-dose vial presentations. The medicine is indicated in specific oncology settings including metastatic breast cancer and certain soft tissue sarcoma cases under physician guidance.
Key Product Information
Generic Name: Eribulin Mesylate
Strength: 0.5mg/ml Injection
Dosage Form: Sterile Injection
Category: Oncology Medicine / Anti-Cancer Drug
Therapeutic Class: Microtubule Inhibitor
Packaging: Export-Oriented Packaging Available
Storage: Store below recommended temperature conditions as per product guidelines
Export Markets: South Africa, Africa, Asia, Middle East, LATAM, CIS Countries
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted Global Pharmaceutical Exporter from India
Reliable pharmaceutical exporter with international supply capabilities
Fast and affordable global shipping solutions
Bulk order support for hospitals, oncology clinics, distributors, and importers
Export documentation assistance
Competitive wholesale pricing
Quality-focused supply chain management
Dedicated customer support for international buyers
Pharmaceutical Export Supply Across South Africa
We supply oncology medicines and specialty pharmaceuticals across:
Gauteng
Western Cape
KwaZulu-Natal
Eastern Cape
Free State
Serving pharmaceutical distributors, hospitals, procurement agencies, wholesalers, oncology centers, and government tenders.
International Buyers We Serve
Pharmaceutical Importers
Hospital Procurement Teams
Oncology Clinics
Government Healthcare Suppliers
Pharmaceutical Distributors
Wholesalers and Stockists
Tender Suppliers
Order Eribulin Mesylate Injection from India
Looking for a reliable supplier of Eribulin Mesylate 0.5mg/ml Injection for import or wholesale supply? Cordium Pharmaceuticals Pvt Ltd offers dependable export support, competitive pricing, secure packaging, and fast shipping solutions worldwide.
Contact Us Today
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
Bulk Orders | Export Enquiries | Distribution Partnerships | International Supply Support
Disclaimer
Product availability, registration status, import requirements, and regulatory approvals vary by country. Supply is subject to applicable pharmaceutical regulations and prescription requirements in destination markets.
Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter and global supplier of Eribulin Mesylate 0.5mg/ml Injection from India, delivering high-quality oncology medicines with fast, reliable, and affordable shipping solutions worldwide. We specialize in pharmaceutical exports to South Africa, including Gauteng, Western Cape, KwaZulu-Natal, Eastern Cape, and Free State.
For Orders & Enquiries
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
What is Eribulin Mesylate 0.5mg/ml Injection?
Eribulin Mesylate Injection is an oncology medication classified as a microtubule inhibitor and is commonly used in advanced cancer treatment protocols under medical supervision. It is available in a concentration of 0.5mg/ml and supplied for institutional and regulated pharmaceutical markets. The formulation strength commonly marketed internationally includes 1mg/2ml single-dose vial presentations. The medicine is indicated in specific oncology settings including metastatic breast cancer and certain soft tissue sarcoma cases under physician guidance.
Key Product Information
Generic Name: Eribulin Mesylate
Strength: 0.5mg/ml Injection
Dosage Form: Sterile Injection
Category: Oncology Medicine / Anti-Cancer Drug
Therapeutic Class: Microtubule Inhibitor
Packaging: Export-Oriented Packaging Available
Storage: Store below recommended temperature conditions as per product guidelines
Export Markets: South Africa, Africa, Asia, Middle East, LATAM, CIS Countries
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted Global Pharmaceutical Exporter from India
Reliable pharmaceutical exporter with international supply capabilities
Fast and affordable global shipping solutions
Bulk order support for hospitals, oncology clinics, distributors, and importers
Export documentation assistance
Competitive wholesale pricing
Quality-focused supply chain management
Dedicated customer support for international buyers
Pharmaceutical Export Supply Across South Africa
We supply oncology medicines and specialty pharmaceuticals across:
Gauteng
Western Cape
KwaZulu-Natal
Eastern Cape
Free State
Serving pharmaceutical distributors, hospitals, procurement agencies, wholesalers, oncology centers, and government tenders.
International Buyers We Serve
Pharmaceutical Importers
Hospital Procurement Teams
Oncology Clinics
Government Healthcare Suppliers
Pharmaceutical Distributors
Wholesalers and Stockists
Tender Suppliers
Order Eribulin Mesylate Injection from India
Looking for a reliable supplier of Eribulin Mesylate 0.5mg/ml Injection for import or wholesale supply? Cordium Pharmaceuticals Pvt Ltd offers dependable export support, competitive pricing, secure packaging, and fast shipping solutions worldwide.
Contact Us Today
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
Bulk Orders | Export Enquiries | Distribution Partnerships | International Supply Support
Disclaimer
Product availability, registration status, import requirements, and regulatory approvals vary by country. Supply is subject to applicable pharmaceutical regulations and prescription requirements in destination markets.
Keywords
